In January 2025, Pune became the focus of India's largest-ever outbreak of a mysterious paralysing illness. Otherwise-healthy young adults, many in their twenties and thirties, started waking up with tingling in their feet. Within hours, weakness climbed upward — first the calves, then the thighs, then the arms. By the second or third day, some couldn't grip a cup or lift their face off the pillow. A few needed ventilators. By mid-March 2025, Maharashtra had recorded 230 cases of Guillain-Barré Syndrome (GBS) and 12 deaths, with Pune alone accounting for 215 cases and 10 fatalities. ICMR investigators later linked the outbreak to contaminated drinking water — specifically to Campylobacter jejuni and norovirus infections from borewell supply to a few affected Pune suburbs.
What makes GBS especially important for Indian families to understand is that it isn't only an outbreak disease. Sporadic cases occur across India year-round, often after a routine diarrhoeal illness or respiratory infection. Because early symptoms are subtle — a bit of numbness, clumsy fingers, a heavy feeling in the legs — many patients lose 24 to 48 hours before they reach a neurologist, and those hours matter. This guide walks you through what GBS is, when to suspect it, which tests confirm the diagnosis, and what treatment costs and recovery really look like in India.
What Is Guillain-Barré Syndrome?
Guillain-Barré Syndrome (GBS) is a rare but serious autoimmune disease in which your own immune system mistakenly attacks the peripheral nerves — the nerves that connect your brain and spinal cord to your muscles and skin. The attack damages the myelin sheath (the insulation around nerve fibres) and sometimes the nerve axons themselves, blocking the electrical signals needed for muscle movement and sensation.
The result is typically ascending paralysis: weakness and numbness that start in the feet and travel upward, eventually reaching the diaphragm in severe cases. Unlike a stroke, GBS is almost always symmetrical — both legs, both arms, both sides of the face — which is an important clue.
GBS is rare worldwide (roughly 1–2 cases per 100,000 people per year), but India sees thousands of cases annually because of the sheer size of the population and high rates of preceding gastrointestinal and respiratory infections.
The Common Triggers
In nearly two-thirds of Indian cases, GBS begins 1 to 4 weeks after a seemingly ordinary infection:
- Campylobacter jejuni — a bacterium carried in under-cooked chicken, contaminated water, and raw salads. This was the main trigger in the 2025 Pune outbreak and is the most common cause of GBS globally.
- Norovirus and rotavirus — gastroenteritis viruses linked to the Pune outbreak.
- Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) — often after a "flu-like" illness.
- Mycoplasma pneumoniae — walking pneumonia.
- Dengue, chikungunya, and Zika — particularly relevant in India's monsoon months. (See our Zika virus guide.)
- COVID-19 and influenza — both have well-documented GBS links.
- Rarely, vaccines — the risk is extremely small and far lower than the risk from the diseases the vaccines prevent.
GBS is not contagious. You can't "catch" GBS from a person who has it; you can only develop it if your own immune system misfires after an infection.
GBS Symptoms: The Warning Signs Indian Patients Miss
Symptoms usually appear 1 to 4 weeks after the triggering infection, though sometimes there is no identifiable trigger at all. The classic pattern evolves over hours to days — not weeks.
Early Symptoms (First 24–48 Hours)
| Symptom | What It Feels Like |
|---|---|
| Tingling or "pins and needles" | Usually starts in toes and fingertips, both sides |
| Mild weakness in legs | Difficulty climbing stairs, getting up from a chair, or squatting |
| Unsteady walking | Feels like walking on cotton or rubber |
| Back pain | Deep, aching lower-back pain is common and often mistaken for muscle strain |
| Loss of reflexes | Knee jerks and ankle jerks disappear early — a classic neurological sign |
Progressive Symptoms (Days 2–14)
Weakness climbs upward — this is the hallmark of GBS:
- Legs → hips → trunk → arms → face → breathing muscles
- Face drooping on both sides, difficulty closing eyes, slurred speech
- Double vision or difficulty swallowing (in variants like Miller-Fisher syndrome)
- Breathing difficulty — the most dangerous complication; about 20–30% of patients need ICU admission and ventilator support
- Heart rate swings, blood pressure instability, urinary retention (signs of autonomic involvement)
When to Rush to a Hospital
Don't wait and watch. If you or a family member has weakness in both legs that is getting worse within hours or days — especially after a recent diarrhoeal or respiratory illness — go directly to a hospital with a neurology department and ICU. Time-to-treatment is one of the strongest predictors of recovery in GBS.
How GBS Is Diagnosed in India
GBS is primarily a clinical diagnosis made by a neurologist based on the typical pattern of ascending weakness and lost reflexes. But three tests confirm it and rule out mimics like spinal cord compression, transverse myelitis, and toxic neuropathies.
1. Nerve Conduction Study (NCS) and Electromyography (EMG)
These are the gold-standard diagnostic tests. Small electrodes measure how fast electrical signals travel along your nerves and how your muscles respond.
- What it shows in GBS: Slowed nerve conduction velocities, prolonged latencies, conduction blocks — patterns of demyelination.
- Timing: May be normal in the first 1–2 weeks; repeat testing at 3 weeks is often more diagnostic.
- Cost in India: ₹2,500–6,000 per study at major hospitals (AIIMS, Fortis, Apollo, Max, Manipal).
2. Lumbar Puncture (CSF Analysis)
A thin needle is inserted between the lumbar vertebrae to collect cerebrospinal fluid (CSF) from around the spinal cord.
- What it shows in GBS: Albumino-cytologic dissociation — high protein with normal white-cell counts. Seen in about 80% of cases after the first week.
- Cost in India: ₹3,000–8,000 including CSF analysis.
3. Blood Tests and MRI
Routine blood tests check for preceding infection (stool culture for Campylobacter, serology for CMV, EBV, Zika, HIV), electrolyte imbalance, and autoimmune markers. An MRI of the spine is done mainly to exclude other causes like cord compression.
- MRI spine cost in India: ₹4,000–10,000.
Upload every report — NCS, CSF, MRI, blood work — to MedicalVault so that during ICU transfers, rehabilitation handovers, and outpatient follow-ups, every neurologist and physiotherapist sees the same timeline. Many GBS patients move between hospitals for IVIg infusion, ventilator support, and rehab — a centralised record prevents dangerous delays.
Treatment: The Two Proven Options
Both proven treatments work by calming the autoimmune attack on the nerves. They are equally effective when started within 2 weeks of symptom onset, and combining them offers no added benefit.
Intravenous Immunoglobulin (IVIg)
IVIg is pooled human antibodies given as a drip for 5 days. It is the most commonly used treatment in India because it requires less specialised equipment than plasma exchange.
- Dose: 0.4 g/kg body weight per day for 5 days (total 2 g/kg).
- Cost in India: IVIg is expensive. A full 5-day course for an average 60 kg adult can cost ₹3–6 lakh in private hospitals, as each vial of IVIg costs ₹8,000–15,000 and a patient needs 12–20 vials. Leading Indian brands include Intraglobin, Immunorel, Globulin-N, and GMH.
- Insurance & schemes: Ayushman Bharat PM-JAY covers GBS treatment in empanelled hospitals up to ₹5 lakh per family per year — see our Ayushman Bharat guide. Many state governments also reimburse IVIg through their chief minister's relief funds on application.
Plasma Exchange (Plasmapheresis)
A machine cycles your blood out, separates the plasma (which contains the damaging antibodies), replaces it with albumin or saline, and returns the blood to you. Usually 5 sessions over 1–2 weeks.
- Cost in India: ₹15,000–30,000 per session, so ₹75,000 to ₹1.5 lakh for a full course — usually cheaper overall than IVIg.
- Availability: Major government institutes (AIIMS, PGIMER, JIPMER, KEM) and tertiary private hospitals.
- Considerations: Requires good vascular access and haemodynamic stability — not ideal for very sick or hypotensive patients.
Supportive Care — Often Lifesaving
Regardless of which immunotherapy is used, patients need intensive support:
- Respiratory monitoring and mechanical ventilation for 20–30% of patients.
- Cardiac monitoring for autonomic instability.
- DVT prophylaxis with low-molecular-weight heparin to prevent blood clots in paralysed limbs.
- Nutrition via nasogastric tube if swallowing is impaired.
- Pain control — neuropathic pain is common and responds to gabapentin or pregabalin rather than standard painkillers.
- Early physiotherapy to prevent joint contractures and pressure sores.
Recovery: What Indian Families Should Expect
Recovery is slow but the long-term outlook is generally good. Most patients begin improving 2 to 4 weeks after symptoms peak, though full recovery can take 6 months to 2 years.
Typical Recovery Pattern
- 60–70% of patients make a full or near-full recovery.
- 20–30% are left with persistent weakness, fatigue or neuropathic pain.
- 5–10% have significant long-term disability.
- 3–7% die, usually from respiratory failure, pneumonia, pulmonary embolism, or autonomic cardiac events.
Rehabilitation is a marathon. Patients typically spend 1–4 weeks in ICU, followed by 2–12 weeks in a ward or rehab centre, and months of outpatient physiotherapy, occupational therapy, and sometimes speech therapy. Psychological support matters — the sudden loss of independence in a previously healthy young adult can trigger depression and anxiety. (Our mental health guide has practical resources.)
GBS Recurrence
Fewer than 5% of patients have a second GBS episode. Recurrence is more common in certain variants like Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), which presents more gradually and requires long-term immunomodulation.
Preventing GBS: What Actually Helps
Because most GBS cases follow infections, prevention focuses on reducing those infections:
- Drink safe water. Boil, filter (RO/UV) or use bottled water in areas with questionable supply. The 2025 Pune outbreak was directly traced to contaminated borewell water.
- Practise food safety. Cook chicken thoroughly to at least 75°C core temperature. Avoid unpasteurised milk and raw salads when eating out.
- Hand hygiene. Wash hands with soap for 20 seconds before eating and after using the toilet — especially during gastroenteritis outbreaks.
- Vaccinate against flu and COVID-19. The risk of GBS from these vaccines is far lower than the risk from the infections themselves.
- Protect against mosquito-borne viruses. See our dengue, chikungunya and Zika guides.
Key Takeaways
- GBS is a post-infectious autoimmune attack on peripheral nerves — not contagious, but triggered by common infections like Campylobacter gastroenteritis, flu, COVID-19, Zika, and dengue.
- The 2025 Pune outbreak — 230 cases, 12 deaths — highlighted how unsafe drinking water can drive sudden GBS spikes in Indian cities.
- Suspect GBS in anyone with ascending weakness, tingling and lost reflexes after a recent infection — and go to a neurologist immediately.
- Nerve conduction studies, CSF analysis and MRI spine confirm the diagnosis.
- IVIg and plasma exchange are equally effective when started within 2 weeks — IVIg costs ₹3–6 lakh, plasma exchange ₹75,000–1.5 lakh; Ayushman Bharat PM-JAY covers GBS treatment.
- 20–30% of patients need ICU and ventilator support; early admission saves lives.
- Recovery takes 6 months to 2 years, with 60–70% making a full recovery.
- Safe drinking water, thoroughly cooked food and good hand hygiene prevent the infections that commonly trigger GBS.
- Upload all your GBS reports to MedicalVault — neurologists, physiotherapists and rehab specialists all need the same timeline of NCS, CSF, IVIg infusions and follow-up scans.
If you notice progressive weakness or tingling that's getting worse day by day — especially after a recent tummy bug or viral fever — don't wait for it to "settle". See a neurologist the same day. Early treatment dramatically changes the outcome. For related reading, explore our guides on Zika virus, stroke, multiple sclerosis, and Ayushman Bharat PM-JAY.